Browse by People

Collapse authors list.
Coen, Oliver, Corrie, Pippa, Marshall, Helen, Plummer, Ruth, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Hook, Jane, Bell, Sue, Sagoo, Gurdeep S, Meads, David, Bestall, Janine et al (show 10 more authors) , Velikova, Galina, Gallagher, Ferdia A, Smith, Alexandra, Howard, Helen, Mason, Ellen, Katona, Eszter, Silva, Shobha, Collinson, Michelle, Rodwell, Simon and Danson, Sarah (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC CANCER, 21 (1). 761-.

Collapse authors list.
Sarker, Debashis, Plummer, Ruth, Meyer, Tim, Sodergren, Mikael H, Basu, Bristi, Chee, Cheng Ean, Huang, Kai-Wen, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ting, Yuk, Evans, TR Jeff et al (show 26 more authors) , Spalding, Duncan RC, Pai, Madhava, Sharma, Rohini, Pinato, David J, Spicer, James, Hunter, Sarah, Kwatra, Vineet, Nicholls, Joanna P, Collin, David, Nutbrown, Robert, Glenny, Helen, Fairbairn, Sonia, Reebye, Vikash, Voutila, Jon, Dorman, Stephanie, Andrikakou, Pinelopi, Lloyd, Peter, Felstead, Steve, Vasara, Jenni, Habib, Robert, Wood, Chris, Saetrom, Pal, Huber, Hans E, Blakey, David C, Rossi, John J and Habib, Nagy (2020) MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial. CLINICAL CANCER RESEARCH, 26 (15). pp. 3936-3946.

Collapse authors list.
Kristeleit, Rebecca ORCID: 0000-0003-3825-1326, Plummer, Ruth, Jones, Robert ORCID: 0000-0001-5608-001X, Carter, Louise, Blagden, Sarah ORCID: 0000-0001-8783-3491, Sarker, Debashis ORCID: 0000-0003-4814-8429, Arkenau, Tobias, Evans, Thomas R Jeffry, Danson, Sarah, Symeonides, Stefan N ORCID: 0000-0002-9892-9314 et al (show 4 more authors) , Veal, Gareth J, Klencke, Barbara J, Kowalski, Mark M and Banerji, Udai ORCID: 0000-0003-1503-3123 (2023) A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer. British journal of cancer, 129 (1). pp. 38-45.

Collapse authors list.
Jones, Robert ORCID: 0000-0001-5608-001X, Plummer, Ruth ORCID: 0000-0003-0107-1444, Moreno, Victor ORCID: 0000-0001-6099-4236, Carter, Louise ORCID: 0000-0002-9854-2304, Roda, Desamparados ORCID: 0000-0003-2657-9623, Garralda, Elena ORCID: 0000-0002-4412-7842, Kristeleit, Rebecca ORCID: 0000-0003-3825-1326, Sarker, Debashis ORCID: 0000-0003-4814-8429, Arkenau, Tobias ORCID: 0000-0002-2015-1549, Roxburgh, Patricia ORCID: 0000-0001-9869-591X et al (show 6 more authors) , Walter, Harriet S ORCID: 0000-0003-2618-711X, Blagden, Sarah ORCID: 0000-0001-8783-3491, Anthoney, Alan ORCID: 0000-0001-5695-8312, Klencke, Barbara J ORCID: 0000-0002-9518-2526, Kowalski, Mark M ORCID: 0000-0001-9590-6259 and Banerji, Udai ORCID: 0000-0003-1503-3123 (2023) A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 29 (2). pp. 331-340.

Collapse authors list.
Hashimoto, Ayumi, Sarker, Debashis, Reebye, Vikash, Jarvis, Sheba, Sodergren, Mikael H, Kossenkov, Andrew, Sanseviero, Emilio, Raulf, Nina, Vasara, Jenni, Andrikakou, Pinelopi et al (show 21 more authors) , Meyer, Tim, Huang, Kai-Wen, Plummer, Ruth, Chee, Cheng E, Spalding, Duncan, Pai, Madhava, Khan, Shahid, Pinato, David J, Sharma, Rohini, Basu, Bristi, Palmer, Daniel ORCID: 0000-0002-7147-5703, Ma, Yuk-Ting, Evans, Jeff, Habib, Robert, Martirosyan, Anna, Elasri, Naouel, Reynaud, Adeline, Rossi, John J, Cobbold, Mark, Habib, Nagy A and Gabrilovich, Dmitry I (2021) Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer. CLINICAL CANCER RESEARCH, 27 (21). pp. 5961-5978.

Collapse authors list.
Danson, Sarah, Plummer, Ruth, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Hook, Jane, Marshall, Helen, Sagoo, Gurdeep, Meads, David, Bestall, Janine, Velikova, Galina, Gallagher, Ferdia et al (show 6 more authors) , Smith, Alexandra, Bell, Sue, Mason, Ellen, Katona, Eszter, Rodwell, Simon and Corrie, Pippa (2019) A randomised phase III multicentre trial to evaluate the duration of anti-PD1 monoclonal antibody monotherapy in patients with metastatic melanoma (DANTE) - Stage 1 Results. .